
SolasCure, a biotechnology company which is dedicated to working towards filling the current market gap in debridement – the removal …
Swedish medtech company Amferia announces the successful completion of its latest investment round, boosting its mission to combat wound infections. …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

